# В. Б. Матвеев

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/a5084120344/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,450 |
| Field | Renal cell carcinoma treatment |
| h-index | 31 |
| i10-index | 70 |
| Last Known Institution | Russian Cancer Research Center NN Blokhin |
| OpenAlex ID | https://openalex.org/A5084120344 |
| ORCID iD | https://orcid.org/0000-0001-7748-9527 |
| Works | 462 |

## Researcher papers

- [Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-placebo-as-post-nephrectomy-adjuvant-therapy-for-clear-cell/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

## Researcher university

- [Russian Cancer Research Center NN Blokhin](https://scholariq.org/institutions/russian-cancer-research-center-nn-blokhin/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.